TNAG-1139-FCO40-1419-Quarterly-progress-reports-on-Hong-Kong-1982 — Page 142

CONFIDENTIAL ##

Subject

13. Buprenorphine

Clinical Trial

(NDC 5/1 II

NDA/12/7)

Purpose

To conduct clinical trials on buprenorph- ine, a possible non- addictive substitute for methadone.

-6-

Progress Made and Present Position

Views of overseas practitioners using buprennorphine in treating drug addicts were sought by the working committee. Technical details of the trial was being finalized.

Next Quarter's Target

To finalize the protocol

and to start the clinical

trial in May/June 1982, pending Finance Committee's approval of fund.

GF 323

CONFIDENTIAL

機密